Identification and characterization of novel endogenous proteolytic forms of the human angiogenesis inhibitors restin and endostatin
- 1 March 2005
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1747 (2) , 161-170
- https://doi.org/10.1016/j.bbapap.2004.10.013
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Role of angiogenesis in tumor growth and metastasisSeminars in Oncology, 2002
- Recent developments in antiangiogenic therapyExpert Opinion on Biological Therapy, 2002
- NC1 Domain of Human Type VIII Collagen (α 1) Inhibits Bovine Aortic Endothelial Cell Proliferation and Causes Cell ApoptosisBiochemical and Biophysical Research Communications, 2001
- Circulating Angiogenesis Regulators in Cancer PatientsThe International Journal of Biological Markers, 2001
- Identification of the Anti-angiogenic Site within Vascular Basement Membrane-derived TumstatinJournal of Biological Chemistry, 2001
- Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activityJournal of Molecular Biology, 2000
- Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor GrowthJournal of Biological Chemistry, 2000
- Inhibitors of Angiogenesis Enter Phase III TestingJNCI Journal of the National Cancer Institute, 1998
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995